abstract |
The present invention relates to new compounds, their composition and use of a compound having a structural formula I, (see formula I) or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which are useful in the treatment or prevention of disorders mediated by a peroxisome proliferator-activated receptor (PPAR), such as X syndrome, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagulopathy, hypertension, arteriosclerosis and other disorders related to X syndrome and cardiovascular diseases. |